Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry

Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry

Background Sex‐based differences in the association of lipoprotein(a) with cardiovascular outcomes have not been well established for those without prior atherosclerotic cardiovascular disease. Methods and Results Patients with no baseline atherosclerotic cardiovascular disease were identified in th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gurleen Kaur, Adam N. Berman, David W. Biery, Stephanie A. Besser, Wanda Y. Wu, Brittany Weber, Michael C. Honigberg, Khurram Nasir, Martha Gulati, Marcelo F. Di Carli, Leslee J. Shaw, Deepak L. Bhatt, Ron Blankstein
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	coronary artery disease lipoprotein(a) myocardial infarction sex differences
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.035353
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Performance of PREVENT equations for cardiovascular risk prediction in young patients with myocardial infarction: From the MGB YOUNG-MI registry
by: Avinainder Singh, et al.
Published: (2025-06-01)

Results of a national survey ‘It’s time for Lp(a)’ regarding the awareness, attitudes and practices of bulgarian cardiologists for testing lipoprotein(a)
by: A. Borizanova, et al.
Published: (2025-05-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Lipoprotein(a) throughout life in women
by: Pablo Corral, et al.
Published: (2024-12-01)

Development of an indirect ELISA based on a new specific lipoprotein LP53 for the detection of antibodies against Mycoplasma synoviae
by: Haoran Li, et al.
Published: (2025-05-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Hypothyroidism consequent to thyroidectomy is associated with elevated remnant lipoproteins and cholesterol enrichment of triglyceride-rich lipoproteins: an observational study
by: Adrian Post, et al.
Published: (2025-04-01)

An Efficacy of Seligi Leaf Flour Fermentation on Cholesterol Levels, Low Density Lipoprotein, and High Density Lipoprotein in Catfish
by: Reza Hardiansyah, et al.
Published: (2022-04-01)

Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing
by: Christof Wedemeyer, et al.
Published: (2025-02-01)

Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
by: Tessa M. Zeis, MD, et al.
Published: (2025-03-01)

Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01)

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin
by: Craig A. Swearingen, et al.
Published: (2025-01-01)

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
by: Robert S. Rosenson, et al.
Published: (2025-06-01)

Association of low-density lipoprotein/high-density lipoprotein ratio with cognition, Alzheimer’s disease biomarkers and brain structure
by: Zihao Zhang, et al.
Published: (2025-04-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

The Impact of Diet on Lipoprotein(a) Levels
by: Michał Stojko, et al.
Published: (2024-10-01)

Prepartum and postpartum concentrations of lipids and lipoproteins in dairy cows
by: Mutlu Sevinç, et al.

Lipoprotein(a) and panvascular disease
by: Ruiyan Xu, et al.
Published: (2025-05-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
by: Isabella Fichtner, et al.
Published: (2024-12-01)

Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men
by: Sophie Galier, et al.
Published: (2024-08-01)

Novel Mycoplasma bovis membrane lipoproteins induce the inflammatory response of host epithelial cells and macrophage
by: Xiaotan Yuan, et al.
Published: (2025-06-01)

Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

High density lipoproteins of blood plasma as a transport form of actinomycin D
by: L. M. Polyakov, et al.
Published: (2019-01-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Efektifitas Probiotik Lactobacillus casei dan Lactobacillus rhamnosus Sebagai Pengganti Antibiotic Growth Promoter Terhadap Total Kolesterol, Low Density Lipoprotein dan High Density Lipoprotein Ayam Broiler
by: Anita Dwi Andriani, et al.
Published: (2020-03-01)

Associations between high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and their ratio with metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
by: Hong Chen, et al.
Published: (2025-06-01)

Influence of proteinuria on the lipoprotein (a) metabolism disorder
by: Petrović Dejan, et al.
Published: (2005-01-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
by: Wong Nathan D.
Published: (2025-01-01)

Lp(a)-Lowering Agents in Development: A New Era in Tackling the Burden of Cardiovascular Risk?
by: Niki Katsiki, et al.
Published: (2025-05-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality among hypertension patients
by: Xiaozhou Su, et al.
Published: (2025-02-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
by: P. V. Pigarevsky, et al.
Published: (2014-07-01)

Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
by: Velilla Teresa Arrobas, et al.
Published: (2025-03-01)

Study on the correlation between oxidized low- density lipoprotein and oxidized high- density lipoprotein with type 2 diabetes complicated by pulmonary tuberculosis
by: Jing Gui, et al.
Published: (2025-05-01)

Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial
by: Rahul Aggarwal, et al.
Published: (2025-03-01)

Focus on lipoprotein(a): The time is now
by: Ya‐hui Lin, et al.
Published: (2023-09-01)